BlackRock Fund Advisors - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 92 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2016$30,697,000
+83.9%
2,034,263
+85.7%
0.01%
+100.0%
Q3 2016$16,691,000
-58.8%
1,095,218
+5.0%
0.00%
-66.7%
Q2 2016$40,493,000
+50.0%
1,043,100
+7.4%
0.01%
+50.0%
Q1 2016$26,992,000
-47.0%
970,940
+2.6%
0.01%
-50.0%
Q4 2015$50,910,000
+43.4%
946,458
+6.7%
0.01%
+33.3%
Q3 2015$35,507,000
+12.1%
886,797
-10.6%
0.01%
+12.5%
Q2 2015$31,688,000
+35.8%
991,786
+1.5%
0.01%
+33.3%
Q1 2015$23,329,000
+176.1%
976,946
+104.1%
0.01%
+200.0%
Q4 2014$8,450,000
+52.1%
478,734
+18.1%
0.00%0.0%
Q3 2014$5,557,000
-21.9%
405,346
-3.9%
0.00%0.0%
Q2 2014$7,115,000421,9930.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q2 2015
NameSharesValueWeighting ↓
DCF Advisers, LLC 424,500$13,499,0005.57%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$6,360,0003.70%
Asymmetry Capital Management, L.P. 130,654$4,155,0001.90%
Altium Capital Management LP 153,348$4,876,0001.82%
Sofinnova Investments, Inc. 848,162$26,972,0001.61%
Bellevue Group AG 3,659,919$116,386,0001.33%
Eversept Partners, LP 356,235$11,328,2731.33%
Rhenman & Partners Asset Management AB 500,000$15,900,0001.30%
GENERAL AMERICAN INVESTORS CO INC 347,497$11,050,0001.09%
WASATCH ADVISORS LP 6,333,900$201,418,0000.99%
View complete list of INTRA CELLULAR THERAPIES INC shareholders